Harald Sourij is Full Professor for Interdisciplinary Metabolic Medicine, the Head of the Cardiometabolic Trials Unit and Deputy Head of the Division of Endocrinology and Metabolism at the Medical University of Graz, Austria. After completing his studies sub auspiciis presidentis (summa cum laude) in 2004 and his training at the Medical University of Graz, Dr Sourij specialised as a consultant in internal medicine, as well as diabetes and endocrinology. 

In 2010 Dr Sourij joined the Diabetes Trials Unit lead by Prof Rury Holman at the University of Oxford, UK, where he acted as the clinical lead for the EXenatide Study of Cardiovascular Event Lowering (EXSCEL) until he returned to Graz, Austria in 2013.
The Cardiometabolic Trials Unit focuses on mono- and multi-center trials, including dietary, physical activity or pharmacological interventions in people with cardiometabolic disorders. The Unit is currently leading the BIO-RISK-EVENT trial, an EU-funded cardiovascular outcome trial. He is also the president elect of the Austrian Diabetes Association.

Harald has published >260 manuscripts in peer reviewed journals, including The Lancet, European Heart Journal, JACC, Diabetes Care or Diabetologia.